FDA OKs Pfizer COVID-19 Vaccine For 12-15 Age Group
Pfizer said in late March that clinical trials found "100% efficacy and robust antibody responses" to the coronavirus in 12- to 15-year-olds.
Read more on NPR
Pfizer said in late March that clinical trials found "100% efficacy and robust antibody responses" to the coronavirus in 12- to 15-year-olds.
Read more on NPR
ConversionConversion EmoticonEmoticon